Navigation Links
PharmaMar Commences Clinical Trial in U.S. with New Antitumor Product, PM060184
Date:2/7/2011

companies: PharmaMar, the world-leading biotechnology company in advancing cancer care through the discovery and development of innovative marine-derived medicines; Noscira, a biotech firm focused on discovering and developing new drugs against Alzheimer's disease and other neurodegenerative diseases of the central nervous system; Genomica, Spain's leading molecular diagnostics company; Sylentis, dedicated to researching therapeutic applications of gene silencing (RNAi); and a chemical division comprising Zelnova and Xylazel, two highly profitable companies that are leaders in their respective market segments.

Important note

PharmaMar, which is headquartered in Madrid (Spain), is a subsidiary of Grupo Zeltia (Spanish stock exchange: ZEL), which has been listed on the Spanish Stock Exchange since 1963 and on Spain's Electronic Market since 1998. This document is a press release, not a prospectus. This document does not constitute or form part of an offering or invitation to sell or a solicitation to purchase, offer or subscribe shares of the company. Moreover, no reliance should be placed upon this document for any investment decision or contract and it does not constitute a recommendation of any type with regard to the shares of the company.

For more information: +34 91 444 4500

This note is also available on the PharmaMar web site: www.pharmamar.com and at Zeltia's web site: www.zeltia.com


'/>"/>
SOURCE PharmaMar
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. PharmaMar Presents New Clinical Trials With Three Marine-Based Drugs at the American Association for Cancer Research Convention
2. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
3. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
4. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
5. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
6. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
7. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
8. Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
9. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
10. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
11. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 2014 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD), ... proprietary technologies and products for advanced microarray diagnostics, ... Master Service Agreement to contract with a UK-based ... During the initial phase of this agreement, SQI ... prototype of one of the customer,s assays, operational ...
(Date:8/21/2014)... , Aug. 21, 2014  Aptuit LLC announces ... Lafayette, Indiana , has enhanced its capabilities ... of small and large molecules, including biologic drugs, ... Bruker maXisPlus Q-TOF mass spectrometer. In ... CEO, Aptuit, said, "The expanded large molecule capability ...
(Date:8/21/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... women,s health, has appointed Holly B. Bauzon ... Ms. Bauzon has a proven track record in ... laboratory services companies. She has more than 20 years ... she held the position of Director, Lab Services Sales ...
Breaking Medicine Technology:SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2
(Date:8/22/2014)... UK (PRWEB) August 22, 2014 The ... recent past, specifically in the developing world, has led ... and the number of deaths due to AIDS globally. ... declining, the number of new patients becoming affected by ... conscious efforts being undertaken by all related organisations and ...
(Date:8/22/2014)... Ohio (PRWEB) August 22, 2014 Dayton Children's ... care tower as part of a $141 million campus renewal. ... patient care tower were unveiled to the public. , ... facilities plan that will create a campus that meets the ... future. These new care spaces will embody Dayton Children’s unique ...
(Date:8/22/2014)... PA (PRWEB) August 22, 2014 Menstrual ... An inventor from Sunrise, Fla., decided that there needed ... , Easy to use and producible in design variations, ... stains caused by leaks, which avoids embarrassment and promotes ... to conventional sanitary pads. , The original design was ...
(Date:8/22/2014)... 22, 2014 (HealthDay News) -- Many children get anxious ... but there are a number of ways that parents ... expert suggests. The first step is to explain ... help protect their health, said Rita John, director of ... University School of Nursing in New York City. ...
(Date:8/22/2014)... Cleveland, Ohio (PRWEB) August 22, 2014 A ... the mood-food connection. The summit is no-cost and open ... their best kept secrets, practical tips and advice on how ... to lose or manage weight. Mindful eating is not ... decisions and stay motivated instead of an "eat this, don't ...
Breaking Medicine News(10 mins):Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 2Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 3Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 2Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 3Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 4Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 5Health News:Simple Steps Make Shots Less Scary for Kids, Nurse Says 2Health News:20 Top Experts Discuss How to Unravel the Food-Mood Connection 2
... Golf can be a good investment for the health, according ... Institutet. The death rate for golfers is 40 per cent ... and socioeconomic status, which correspond to a 5 year increase ... safest. , It is a well-known fact that exercise ...
... 2008) Results from a pivotal Phase III ... oral, once-daily, investigational anticoagulant medication, was superior in ... total knee replacement (TKR) surgery. The head-to-head study ... enoxaparin, the current standard of care. , Data ...
... May 30 Lutronic, Inc., one of,the world,s ... today that its MOSAIC eCO2 system, the next ... the deep,ablative features of a CO2 laser, is ... With intuitive touch-screen software, the powerful MOSAIC ...
... May 30 /PRNewswire-FirstCall/ - Predictive medicine company,PreMD Inc. ... been notified by,the American Stock Exchange (the "AMEX") ... for regaining compliance with the continued listing,standards and ... stock from the,Exchange by filing a delisting application ...
... less likely than white women to receive the radiation ... according to a study that Dana-Farber Cancer Institute researchers ... Society of Clinical Oncology in Chicago. , Although the ... that thousands of black and Hispanic breast cancer patients ...
... COLUMBUS, Ohio Medical researchers at The Ohio State ... a $34 million grant from the National Institutes of ... translational protocols that help identify and advance treatments for ... received by Ohio State. , The Ohio State University ...
Cached Medicine News:Health News:Golf prolongs life 2Health News:Rivaroxaban phase III pivotal data presented at EFORT annual meeting 2Health News:Rivaroxaban phase III pivotal data presented at EFORT annual meeting 3Health News:Soon to Be Released: Lutronic Announces the MOSAIC eCO2, the World's First 'Smart' Fractional CO2 Laser System for Treating Aesthetic and Dermatological Conditions, Will Soon Be Coming to the U.S. Market for Commercial Use 2Health News:Soon to Be Released: Lutronic Announces the MOSAIC eCO2, the World's First 'Smart' Fractional CO2 Laser System for Treating Aesthetic and Dermatological Conditions, Will Soon Be Coming to the U.S. Market for Commercial Use 3Health News:Delisting Notification Received from the American Stock Exchange 2Health News:Blacks, Hispanics less likely than whites to receive follow-up radiation for early breast cancer 2Health News:Ohio State receives $34M NIH grant 2
... developed to create physically secured rooms that ... are converted to RFID portals. These Intelli-Storeroom™ ... antennas by VerdaSee's Field Engineering experts. RFID ... that are to be tracked. The assets ...
... enabled Med Station provides a real time ... during anesthesia. The portable workstation automatically tracks ... removed. The system automatically reorders product from ... tracks expiration dates, catalog numbers and lot ...
... VerdaSee Location-ID™ is a family ... track equipment and individuals inside hospitals, ... radio frequency technology. The target tracking ... through a series of radio frequency ...
Assetrac allows identification, location, and protection of your assets....
Medicine Products: